Close
Close

BioTech Pharma Summit: Orphan Drugs for Rare Diseases 2019

1.0
1.0 from 1 vote
Date: 24 - 25 October, 2019
Location: Seoul, South Korea

On 24 & 25 October 2019, Seoul (South Korea) will host the BioTech Pharma Summit: Orphan Drugs for Rare Diseases 2019 conference. This year's event will bring together government, hospitals, pharmaceuticals, biopharmaceuticals, non-profit organisations, orphan drugs developers as well as regional and local manufacturers. We are putting together an agenda that address the driving macroeconomic factors, policies and issues that will steer the development of orphan drugs globally including commercialisation, policies, reimbursement, pricing and more.

Orphan Drugs for Rare Diseases 2019 features more than 20 speakers from FDA, EMA, NIH and the orphan product industry, more than 80 thought leaders from the patient community and industry, will provide a unique opportunity to hear from the experts and join the conversation on issues of unprecedented importance.

With the global Orphan Drug market expected to grow to $127 billion by 2018-2019, and another Rare Disease Day just having passed, there is a constantly growing awareness and interest for this industry, enabling more research to make a difference in patients' lives. Orphan Drugs for Rare Diseases 2018 conference will bring together some of the leading senior industry professionals to network, learn, and discuss current issues in the rare disease industry.

Orphan Drugs for Rare Diseases 2019 has evolved from a one track conference focused on regulatory pathways, policy and incentives, to a global gathering of 200+ leaders in orphan drugs from 30+ countries and over 20+ presentations and case studies covering all aspects of orphan drug development and rare disease research.

The BioTech Pharma Summit: Orphan Drugs for Rare Diseases 2019 will help connect industry professionals internationally, ensuring there is a great networking and learning opportunity to share knowledge of research, developments and issues. With topics being discussed such as Cell and Gene Therapy; Patient Recruitment and Patient-centric Research; Clinical Development, Regulatory Guidelines; Strategic Partnerships; Pricing and Reimbursement; and many more, this year's conference promises to be the perfect platform to exchange knowledge and network with your peers!

KEY PRACTICAL LEARNING POINTS
Future Outlook for Patient Assistance Programs
Challenges, Opportunities And Treatment Of Rare Diseases
Current Topics from the FDA
Cutting-edge science and tech to enhance rare diseases research, diagnosis and therapeutics
Novel drug modalities, assays & models, therapeutic strategies
Successful patient recruitment and project delivery in rare indications
The Challenge of Healthcare Costs and Treatment Prices
Sustaining Orphan Drug Development and Availability
Developing a state of art telemedicine rare disease service
Novel approaches for the genetic therapy of rare diseases
Artificial intelligence to advance rare disease treatments
Employee wellbeing & health in relation to office design
Investor Perspective: The Outlook for Investment in Orphan Products
Emerging approaches for effective, fast, affordable and successful orphan drugs development
Rare Disease Drug, Biologic and Device Development: Achievements and Opportunities
Global Orphan Drug Regulatory Strategy
Drug repurposing for rare diseases
Insights into regulatory, pricing, reimbursement, commercialization, market access for rare disorders drugs

WHO SHOULD ATTEND?

The BioTech Pharma Summit (EPM Group) are exclusive events consisting of world-class keynote addresses and presentations designed specifically for senior level attendees from research & academic institutions, clinical research institutions and hospital laboratories as well as major pharmaceutical and biotech companies based Worldwide. Delegates typically include CEOs, VPs, Drug developers, Academics and Researchers, CROs, Scientists and Medical Doctors of:

Drug Discovery & Development
Personalized Medicine
Translational Medicine
Experimental Medicine
Innovative Medicine
Stratified Medicine
Regenerative Medicine
Cell / Molecular Biology
Molecular Diagnostics
Diagnostic Development
Cell / Gene Therapy
Targeted Therapy
Rare & ultra-rare Diseases
Genetic Diseases
Metabolic & Gastrointestinal (GI) disorders
Haematology
Immunology
Non-Hodgkin Lymphoma
Acute Myeloid Leukemia
Cystic Fibrosis
Glioma
Pancreatic Cancer
Ovarian Cancer
Multiple Myeloma
Duchenne Muscular Dystrophy
Graft vs Host Disease
Renal Cell Carcinoma
Clinical Research / Trials / Development
Neurology, mental health, neuromuscular and musculoskeletal disorder
Dermatology, ophthalmology, urology and nephrology Immunology
Endocrinology
Cardiovascular, pulmonological disorders
Cancer / Oncology
Market Access
Pricing & Reimbursement
Alliance Management
Patient Advocacy
n-Licensing/Out-Licensing
Regulatory & Medical Affairs
Commercial Development
Health Economics/Outcomes Research (HEOR)
Orphan Foundations/Associations
Bioinformatics
Big Data
Digital Health

 

 

Contact
Phone: +351 221 102 132
1.0
1.0 from 1 vote